| Title |
Circulating Tumor Cells, Disease Progression, and Survival in Metastatic Breast Cancer
|
|---|---|
| Published in |
New England Journal of Medicine, August 2004
|
| DOI | 10.1056/nejmoa040766 |
| Pubmed ID | |
| Authors |
Massimo Cristofanilli, G. Thomas Budd, Matthew J. Ellis, Alison Stopeck, Jeri Matera, M. Craig Miller, James M. Reuben, Gerald V. Doyle, W. Jeffrey Allard, Leon W.M.M. Terstappen, Daniel F. Hayes |
X Demographics
The data shown below were collected from the profiles of 53 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 13 | 25% |
| Spain | 6 | 11% |
| Italy | 4 | 8% |
| Australia | 3 | 6% |
| Canada | 2 | 4% |
| China | 1 | 2% |
| Colombia | 1 | 2% |
| Germany | 1 | 2% |
| Mexico | 1 | 2% |
| Other | 5 | 9% |
| Unknown | 16 | 30% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 27 | 51% |
| Scientists | 15 | 28% |
| Practitioners (doctors, other healthcare professionals) | 11 | 21% |
Mendeley readers
The data shown below were compiled from readership statistics for 1,113 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 9 | <1% |
| Italy | 3 | <1% |
| Germany | 3 | <1% |
| France | 2 | <1% |
| Netherlands | 2 | <1% |
| Spain | 2 | <1% |
| Israel | 1 | <1% |
| United Kingdom | 1 | <1% |
| Saudi Arabia | 1 | <1% |
| Other | 5 | <1% |
| Unknown | 1084 | 97% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 197 | 18% |
| Researcher | 165 | 15% |
| Student > Master | 126 | 11% |
| Student > Bachelor | 92 | 8% |
| Student > Doctoral Student | 66 | 6% |
| Other | 177 | 16% |
| Unknown | 290 | 26% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 215 | 19% |
| Biochemistry, Genetics and Molecular Biology | 180 | 16% |
| Agricultural and Biological Sciences | 139 | 12% |
| Engineering | 97 | 9% |
| Chemistry | 49 | 4% |
| Other | 106 | 10% |
| Unknown | 327 | 29% |
Attention Score in Context
This research output has an Altmetric Attention Score of 108. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 December 2023.
All research outputs
#393,845
of 25,837,817 outputs
Outputs from New England Journal of Medicine
#5,757
of 32,687 outputs
Outputs of similar age
#329
of 66,825 outputs
Outputs of similar age from New England Journal of Medicine
#7
of 147 outputs
Altmetric has tracked 25,837,817 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 32,687 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 122.6. This one has done well, scoring higher than 82% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 66,825 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 147 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 95% of its contemporaries.